September 24, 2025
GAL1 Becomes A New Anticancer Target
On June 10, 2025, Diego O. Croci, Gabriel A. Rabinovich, and others from the Institute of Biology and Experimental Medicine (IBYME) and the Institute of Histology and Embryology of Mendoza (IHEM) in Argentina published an article titled "Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells" in Immunity. This study found that the […]
Read More >
